Heidi V Russell

7PUBLICATIONS
30CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyHaematological tumoursSocial epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 11, 2024
Comparing the Diagnostic Yield of Germline Exome Versus Panel Sequencing in the Diverse Population of the Texas KidsCanSeq Pediatric Cancer Study.

Lauren R Desrosiers-Battu, Tao Wang, Jacquelyn Reuther

|Oct 08, 2021
Rising drug cost impacts on cost-effectiveness of 2 chemotherapy regimens for intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group.

Heidi V Russell, Yueh-Yun Chi, M Fatih Okcu

|May 24, 2021
A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study.

Brian D Weiss, Gregory Yanik, Arlene Naranjo

|Jul 31, 2020
Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors.

Sarah B Whittle, Valeria Smith, Allison Silverstein

|Jul 06, 2019
Using the Delphi method to identify clinicians' perceived importance of pediatric exome sequencing results.

Hadley Stevens Smith, Heidi V Russell, Brendan H Lee

|Apr 17, 2019
Payer and race/ethnicity influence length and cost of childhood cancer hospitalizations.

Sarah B Whittle, Michelle A Lopez, Heidi V Russell

Pageof 2

Frequent Collaborators

2 joint publications

Sarah B Whittle

1 joint publications

Brian D Weiss

1 joint publications

Fan F Zhang

1 joint publications

Barry L Shulkin